SAN DIEGO, Sept. 16, 2026 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disease, today announced that four abstracts from its off-the-shelf CAR T-cell programs have been selected for presentation at the American College of Rheumatology (ACR) Convergence 2026, being held November 6-11 in Orlando, Florida.

Presentations span clinical, translational, and patient-centered research across the Company’s autoimmune focused, off-the-shelf, iPSC-derived CAR T-cell pipeline, including FT819 and FT839. Two FT819 presentations will feature updated clinical data, including administration of FT819 without the use of conditioning chemotherapy, the overview of a unique biomarker association with quality-of-life improvement, and continued progress on outpatient administration to expand community-based access, including in underserved regions. A third presentation details a patient perspective focus group study conducted in collaboration with the Lupus Foundation of America, which explores patient preferences for off-the-shelf, allogeneic CAR T-cell therapy in lupus. The final presentation will provide an update on preclinical studies and the design and progress of the COMPLETE Trial, a recently cleared Phase 1/2 clinical trial of FT839, the company’s off-the-shelf, dual-CAR T-cell product candidate co-targeting CD19 and CD38 for the comprehensive elimination of multicellular drivers of autoimmune diseases, including in rheumatoid arthritis (RA).

“The breadth of clinical progress we have made as a team and are sharing at the ACR Convergence reflects both the maturation of our off-the-shelf CAR T-cell portfolio in autoimmune disease and our commitment to making cell therapy accessible to all patients in need of such transformative therapy,” said Bob Valamehr, President and Chief Executive Officer of Fate Therapeutics. “We continue to observe an encouraging and class-leading safety and tolerability profile for FT819, along with meaningful clinical outcomes that are driving enrollment and clinician engagement as well as enabling CAR T-cell administration in the outpatient and community setting with same-day discharge, a unique and meaningful step in extending access beyond specialized treatment centers. Through our continued partnership with the Lupus Foundation of America to keep the patient voice at the center of our work, a patient perspective presentation reinforces our conviction that cell therapy delivered with less intensive or no conditioning chemotherapy, in an off the shelf setting, is preferred and can simplify the CAR T-cell treatment paradigm to improve quality of life for people living with such challenging disease.”

Details of the presentations are as follows:

Title: FT839: An Off-the-Shelf, Dual CAR T-Cell Therapy for the Comprehensive Elimination of Multicellular Drivers of Rheumatoid Arthritis

Presentation Type: Poster

Session: Poster Session A, Rheumatoid Arthritis – Treatment

Date and Time: Sunday, November 8, 2026, 10:30 a.m. – 12:30 p.m. ET

Abstract #: 0453

Title: Off-the-Shelf CD19 CAR T-cell Therapy Demonstrates Feasibility of Outpatient Administration, Expanding Access to Community-Based Care

Presentation Type: Poster

Session: Poster Session B, Systemic Lupus Erythematosus – Treatment

Date and Time: Monday, November 9, 2026, 10:30 a.m. – 12:30 p.m. ET

Abstract #: 1234

Title: Off-the-Shelf Anti-CD19 CAR T-cell Therapy Efficacy Reveals Biomarker Candidates for Fatigue in SLE

Presentation Type: Poster

Session: Poster Session B, Systemic Lupus Erythematosus – Etiology & Pathogenesis

Date and Time: Monday, November 9, 2026, 10:30 a.m. – 12:30 p.m. ET

Abstract #: 1024

Title: Patient Perspectives on Allogeneic CAR T Cell Therapy in Systemic Lupus Erythematosus: Findings from a Focus Group Study (Part 3)

Presentation Type: Poster

Session: Poster Session B, Patient Outcomes, Preferences, & Attitudes

Date and Time: Monday, November 9, 2026, 10:30 a.m. – 12:30 p.m. ET

Abstract #: 1539

The accepted abstracts can be accessed on the ACR Convergence 2026 website. Presentation materials will be available following the event on the Fate website, located here: Fate Publications & Presentations.

About FT819

FT819 is an off-the-shelf CD19-targeting chimeric antigen receptor (CAR) T-cell product candidate engineered to improve safety and efficacy. Analogous to master cell banks used to mass produce biopharmaceutical drug products such as monoclonal antibodies, a precisely engineered clonal master induced pluripotent stem cell (iPSC) bank serves as the starting cell source to manufacture FT819, overcoming numerous limitations associated with patient- and donor-sourced CAR T-cell therapies. FT819 is well-defined and uniform in composition, produced at a low cost of goods, and can be stored in inventory for off-the-shelf, on-demand availability to enable access for a broad patient population. This research was additionally made possible by funding from the California Institute for Regenerative Medicine (CIRM), a state agency in California that supports research in regenerative medicine, stem cell therapy, gene therapy, and clinical trials. (Grant number: CLIN2-16303)

About FT839

FT839 is the Company’s first multi-antigen, dual-CAR T-cell product candidate, designed to express two unique CARs—a first CAR targeting the B-cell lineage marker CD19 and a second CAR targeting CD38—to enable the comprehensive elimination of multiple cellular drivers of autoimmune disease. FT839 is armed with the Company’s novel Sword & Shield™ technology, which is designed to eliminate the need for conditioning chemotherapy. Following FDA clearance of its Investigational New Drug (IND) application, FT839 is advancing into a Phase 1/2 basket trial to evaluate FT839 across autoimmune indications, including rheumatoid arthritis, SLE, systemic sclerosis (SSc), ANCA-associated vasculitis (AAV), and idiopathic inflammatory myopathy (IIM).

About Fate Therapeutics, Inc.

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s pipeline includes iPSC-derived T-cell and natural killer (NK) cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 including statements regarding the Company’s product candidates, clinical studies and preclinical research and development programs, the Company’s progress, plans and timelines for the clinical investigation of its product candidates, including the initiation and continuation of enrollment in the Company’s clinical trials, the initiation of additional clinical trials, including in new indications, and additional dose cohorts in ongoing clinical trials of the Company’s product candidates, the availability of data from the Company’s clinical trials and the Company’s plans to provide updates on its clinical trials, the therapeutic and market potential of the Company’s research and development programs and product candidates, the Company’s clinical and product development strategy, and the Company’s progress and plans relating to, and the anticipated timing and outcome of, interactions with the FDA and other regulatory authorities, including its expectations relating to alignment with regulatory authorities on potential registrational pathways for FT819. These and any other forward-looking statements in this release are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that the Company’s research and development programs and product candidates, including those product candidates in clinical investigation, may not demonstrate the requisite safety, efficacy, or other attributes to warrant further development or to achieve regulatory approval, the risk that results observed in prior studies of the Company’s product candidates, including preclinical studies and clinical trials, will not be observed in ongoing or future studies involving these product candidates, the risk of a delay or difficulties in the manufacturing of the Company’s product candidates or in the initiation and conduct of, or enrollment of patients in, any clinical trials, the risk that the Company may cease or delay preclinical or clinical development of any of its product candidates for a variety of reasons (including requirements that may be imposed by regulatory authorities on the initiation or conduct of clinical trials, changes in the therapeutic, regulatory, or competitive landscape for which the Company’s product candidates are being developed, the amount and type of data to be generated or otherwise to support regulatory approval, difficulties or delays in patient enrollment and continuation in the Company’s ongoing and planned clinical trials, difficulties in manufacturing or supplying the Company’s product candidates for clinical testing, failure to demonstrate that a product candidate has the requisite safety, efficacy, or other attributes to warrant further development, and any adverse events or other negative results that may be observed during preclinical or clinical development), the risk that its product candidates may not produce therapeutic benefits or may cause other unanticipated adverse effects, and risks relating to regulatory interactions and the outcome of such interactions. For a discussion of other risks and uncertainties, and other important factors, any of which could cause the Company’s actual results to differ from those contained in the forward-looking statements, see the risks and uncertainties detailed in the Company’s periodic filings with the Securities and Exchange Commission, including but not limited to the Company’s most recently filed periodic report, and from time to time in the Company’s press releases and other investor communications. Fate Therapeutics is providing the information in this release as of this date and does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact:

Ryan Douglas
Fate Therapeutics, Inc.
IR@fatetherapeutics.com

VANCOUVER, British Columbia, Sept. 16, 2026 (GLOBE NEWSWIRE) — K2 Gold Corporation (“K2” or the “Company”) (TSX-V: KTO | OTCQX: KTGDF | FSE: 23K) today announced initial gold-solubility results from the Dragonfly Zone at its 100%-owned Mojave Project in Inyo County, California. A total of 211 mineralized samples from seven holes drilled in 2026 return a soluble-gold-to-fire-assay-gold ratio (“AuCN/AuFA ratio”) of 97.1% based on the ratio of summed CN-soluble and fire-assay gold grades. Initial soluble gold recoveries combined with field observations confirm the presence of readily leachable gold in an oxide environment to depths of up to 180 meters below surface – the limit of drilling to date. Aggregate ratios for the individual holes ranged from 93.4% to 99.9%.

Furthermore, K2 conducted soluble gold check assays in 2020 on 206 paired samples from nine holes covering Dragonfly and Newmont and these data returned an aggregate AuCN/AuFA ratio of 95.0%. Collectively, the 2026 and 2020 results are encouraging and consistent with the extensive visual oxidation documented in K2’s drilling at Dragonfly and Newmont.

Highlights

  • Strong initial gold solubility: 211 mineralized samples from seven 2026 Dragonfly holes returned a 97.1% aggregate AuCN/AuFA ratio, with individual-hole aggregate ratios ranging from 93.4% to 99.9%.
  • K2’s 2020 results support the 2026 data: 206 samples from 9 holes drilled at Dragonfly and Newmont in 2020 return a 95.0% aggregate AuCN/AuFA ratio.
  • Iron oxide rich sedimentary rocks have been documented throughout K2’s drilling at both Dragonfly and Newmont historically and through the current drilling program with visible oxidation within the gold-bearing structures tested to date.
  • Previously reported intervals demonstrate high initial gold solubility ratios: 3.05m of 17.55 g/t Au in DF26-024 returned a 97.0% AuCN/AuFA ratio, and 18.29m of 3.77 g/t Au in DF26-018 returned a 99.4% AuCN/AuFA ratio.
  • Drilling completed by previous operators indicate oxidation to depths of at least 237m depth, and preliminary “cyanide shake” tests on the mineralization by BHP indicated recoveries up to 91% on material >0.5 g/t Au (see Great Bear Resources news release dated Oct. 30, 2013, here).
  • K2 is planning to conduct preliminary representative bottle-roll metallurgical testing to evaluate gold extraction, extraction over time and reagent consumption under controlled laboratory conditions.

“The results provide an encouraging first indication that a high proportion of the gold in the Dragonfly samples tested is readily soluble,” stated Anthony Margarit, President and CEO of K2 Gold. “This is consistent with the widespread deep oxidation profile we have visually observed in drilling at Dragonfly and Newmont. The next step is a more comprehensive bottle-roll program designed to evaluate gold extraction using representative mineralized material.”

Oxide Mineralization Across Dragonfly and Newmont

K2’s geological logging has documented deep oxidized mineralization profiles in all drilling completed by the Company to date at Dragonfly and Newmont. At Dragonfly, visual oxidation has been observed throughout the gold-bearing structures tested in the 2020 and 2026 programs. At Newmont, K2’s 2020 drilling intersected oxidized gold mineralization in pervasive iron oxide rich environments, including 41.15 m grading 1.69 g/t Au from 44.20 m in hole NM20-011.

Historical operators, including Newmont Exploration and BHP Minerals, also completed limited drilling in the broader project area and their data report well oxidized sedimentary rock across both targets. K2 is continuing to review available historical drill information alongside its own geological observations. The physical evidence of oxidation, very low sulphur geochemistry, and the high AuCN/AuFA ratios provide complementary indications that this preliminary test work conducted on Dragonfly and Newmont mineralization has responded quite favorably and future, more extensive metallurgical test work may respond well to conventional leach testing methods. Metallurgical testing is required before conclusions can be made regarding processing performance or potential recovery.

Initial Dragonfly Cyanide Soluble Gold Results – 2026

ALS Laboratories has analyzed 2026 samples from the first seven drill holes in this year’s program that returned more than 0.100 g/t Au by initial fire assay using method Au-AA13. K2 compared each cyanide-soluble gold result with the corresponding fire-assay result and calculated the AuCN/AuFA ratio. Because the sample set includes only samples above the stated gold threshold, the results should not be interpreted as representative of all drilled material.

Table 1: Hole-by-hole aggregate AuCN/AuFA ratio, as well as mean and median individual ratios (equal-weight).

Drill hole Paired
samples
Aggregate
AuCN/AuFA*
Mean individual
ratio
Median individual
ratio
DF26-018 25 99.2 % 98.2 % 97.9 %
DF26-019 19 93.4 % 93.5 % 93.2 %
DF26-020 38 96.4 % 91.0 % 95.8 %
DF26-021 27 96.7 % 91.9 % 94.2 %
DF26-022 30 95.1 % 94.0 % 95.3 %
DF26-023 36 99.9 % 90.8 % 98.6 %
DF26-024 36 96.2 % 84.1 % 95.1 %
2026 Overall 211 97.1 % 91.4 % 95.9 %
               

211 unique samples from DF26-018 through DF26-024, each representing a five-foot reverse circulation drill interval equivalent to approximately 1.52m were analysed and compared. The aggregate ratio is calculated as 100 × the sum of soluble-gold results divided by the sum of fire-assay results. Each sample represents an approximately 1.52 m drill interval. The arithmetic mean gives each individual sample ratio equal weight, while the median represents the middle sample ratio. These analytical ratios provide a preliminary indication of the potential amenability of the tested mineralization to cyanide leaching, including potential heap-leach processing.

2020 K2 Gold Results

The 2020 dataset comprises select coarse-reject splits originally analyzed by MSA Laboratories that were submitted to Bureau Veritas Laboratories for check fire-assay and cyanide-soluble gold analysis following the 2020 drill program. Across 206 samples with check fire-assay gold greater than 0.100 g/t Au, the combined ratio of summed CN to summed check-FA grades is 95.0%, with a mean individual ratio of 90.9% and a median of 94.2%. Dragonfly and Newmont separately return ratios of summed grades of 95.0% and 94.9%, respectively.

Table 2: 2020 drill hole-by-hole aggregate AuCN/AuFA ratio, as well as mean and median individual ratios (equal-weight).

Drill Hole Paired
samples
Aggregate
AuCN/AuFA
Mean individual
ratio
Median individual
ratio
DF20-001 20 96.9 % 99.8 % 98.1 %
DF20-002 43 95.7 % 88.0 % 93.2 %
DF20-003 32 95.2 % 86.0 % 91.8 %
DF20-004 26 93.1 % 91.8 % 92.0 %
DF20-006 23 96.7 % 89.4 % 92.5 %
Dragonfly Subtotal 144 95.0 % 90.1 % 93.0 %
NM20-010 16 96.8 % 93.6 % 95.1 %
NM20-011 28 91.9 % 93.9 % 96.6 %
NM20-016 11 98.0 % 87.9 % 94.3 %
NM20-017 7 102.4 % 93.0 % 105.3 %
Newmont Subtotal 62 94.9 % 92.7 % 95.8 %
2020 overall 206 95.0 % 90.9 % 94.2 %
               

The ratios above compare Bureau Veritas soluble-gold results with Bureau Veritas check fire assays; they do not use the original MSA Laboratories assays reported for the 2020 drill intercepts. Because these were selected check-assay samples, they should not be interpreted as representative of all material drilled in 2020.

Next Steps and Drilling Update

K2 is planning a more comprehensive bottle-roll program with a qualified metallurgical laboratory. Representative composites are expected to be selected across a range of gold grades, rock types, oxidation intensities and locations within the Dragonfly mineralized structures. The program is expected to evaluate gold extraction over time, cyanide and lime consumption and the effect of particle size, supported by head and residue assays. The final scope and timing remain subject to sample availability and laboratory consultation. Bottle-roll results will help guide any subsequent metallurgical work but will not, on their own, establish commercial-scale recovery.

K2 has also completed eight holes at the Newmont target, approximately 2 km south of Dragonfly along the greater than 6.5 km long Eastside Gold Trend. The Company will continue to release results upon receipt and interpretation throughout the ongoing, fully permitted, drilling program.

Qualified Person (“QP”) and QA/QC

The technical information in this news release has been prepared in accordance with Canadian regulatory requirements set out in NI 43-101 and reviewed and approved by Eric Buitenhuis, M.Sc., P.Geo., K2’s QP and Vice President of Exploration.

The analytical work for the 2026 drilling program was performed by ALS Laboratories (“ALS”) an internationally recognized and accredited analytical services provider. All samples were submitted to ALS’s Reno, Nevada facility, where they were prepared using procedure PREP-31Y (dry, crush entire sample to 2mm, rotary split and pulverize 250g to better than 85% passing 75 microns). Samples were then shipped to the ALS laboratory in North Vancouver, BC, Canada, where pulp samples were analysed for gold by method Au-ICP21, a 30-gram Fire Assay fusion with an ICP-AES finish. Samples returning >10 g/t Au by Fire Assay were subsequently analysed with method Au-GRA21, a 30-gram fire assay with a gravimetric finish. A 0.25g pulp was analysed by method ME-MS61, a 4-acid digestion and ICP-MS finish for 48 elements. Samples with fire-assay gold greater than 0.100 g/t were selected for additional cyanide-soluble gold analysis by Au-AA13, a 30g cyanide leach with an atomic absorption spectroscopy (“AAS”) finish.

Samples from the 2020 Dragonfly and Newmont drilling were initially prepared and analysed by MSA Laboratories. Selected splits of retained coarse-reject material were subsequently submitted to Bureau Veritas (“BV”) for preparation, check fire-assay and cyanide-soluble gold analysis. Check assay samples were riffle split by method SPTRF and pulverized to 85% passing 200 mesh by method PUL85, then analysed for gold by method FA430, a 30-gram Fire Assay fusion with an ICP-AAS finish. Samples returning >10 g/t Au by Fire Assay were subsequently analyzed with method FA530, a 30-gram fire assay with a gravimetric finish. The BV cyanide-soluble analyses used method CN401, a 15g, 30mL cyanide leach with an AAS finish. The 2020 AuCN/AuFA ratios reported in this release compare BV cyanide-soluble gold with the corresponding BV check fire-assay results, rather than the original MSA assays.

Quality Assurance and Quality Control procedures include inserting coarse blanks and certified assay standards into the sample string at a rate of approximately 1/10 (10%). K2 personnel placed samples in sealed bags and shipped them to ALS.

About K2 Gold Corporation

K2 is a gold focused exploration company primarily operating in the SW USA and Yukon territory of Canada. The company is led by an experienced team with a track record of success including Great Bear, Great Bear Royalties, Kaminak and Northern Empire. The company is well financed with a treasury of over $27M.

K2 holds:

The Mojave Project is a +6000-hectare oxide gold project with base metal targets located in Inyo County, California. Multiple previously recognized surface gold targets have been successfully drilled in the past, most notably by Newmont and BHP. Since acquiring the property, K2 has completed geochemical and geophysical surveys, geologic mapping, LiDAR, a WorldView 3 alteration survey, and successfully completed a 17-hole RC drill program focused on the Dragonfly and Newmont Zones. Highlights from K2’s drilling program include 6.68 g/t Au over 45.72m from surface at the Dragonfly Zone, and 1.69 g/t Au over 41.15m from 44.20m depth at the Newmont Zone. A follow-up phase of drilling at Mojave is currently underway and will continue for the remainder of 2026. See Mojave 43-101 report here.

The Si2 Project is a low-sulphidation epithermal gold system located in Nevada within the Walker Lane Trend. Historical shallow drilling tested only the uppermost levels of the system and returned anomalous gold, silver, and pathfinder elements. Since acquiring the project, K2 has completed detailed geologic mapping, surface geochemistry, geophysics, alteration mineralogy studies, fluid inclusion analysis, and age dating. These integrated datasets confirm that prior drilling did not test the interpreted boiling zone, where gold grades are typically maximized in epithermal systems. In early 2026, K2 completed an 8-hole, 3,871m exploration drilling program targeting the depths of the system and successfully intersected broad intervals of gold mineralization and blind-to-surface quartz veining.

The Wels Project lies approximately 60km south of Fuerte Metals Coffee project discovered by Kaminak Gold Corporation (formerly a Discovery Group company prior to its acquisition by Goldcorp-Newmont). Both the Coffee project and the Wels project lie within the Tintina Gold Belt, share similar characteristics, and are host to structurally controlled gold mineralization within intrusive rocks exhibiting multiple trends of mineralization. K2’s drilling at the Wels Project has returned strong results including: 3.53g/t Au over 19.5m, and 10.38g/t Au over 6.0m.

The Wolf Project is a new district-scale gold exploration project in west-central Yukon Territory, Canada, located 80 km south of the 3.0 Moz Au Coffee Gold Project currently under development by Fuerte Metals. Wolf consists of the Wolf South block, a >10km long gold-in-soil anomaly previously held by multiple operators and consolidated by K2, and the Wolf North claim blocks which host greenfield intrusion-related and epithermal gold targets.

K2 Gold is committed to responsible exploration, safety, Indigenous and community engagement, and advancing high-quality projects through a collaborative and technically disciplined approach.

On behalf of the Board of Directors,

(signed) “Anthony Margarit”

Anthony Margarit,
President and Chief Executive Officer

Investor Inquiries
info@k2gold.com | +1 (604) 331-5090

For additional information about K2 Gold Corporation, please visit K2Gold.com

Follow Us On Social Media: LinkedIn | Instagram | X | YouTube

K2 Gold Corporation is a member of Discovery Group, based in Vancouver, Canada. For more information, please visit: discoverygroup.ca

Cautionary Statement on Forward-Looking Statements

This news release contains forward-looking statements that are not historical facts. Forward- looking statements involve risks, uncertainties and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements, including statements regarding the exploration program at Si2, Wels, and Mojave, including results of drilling, and future exploration plans at Si2, Wels, and Mojave. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, variations in the nature, quality and quantity of any mineral deposits that may be located, the Company’s inability to obtain any necessary permits, consents or authorizations required for its planned activities, and the Company’s inability to raise the necessary capital or to be fully able to implement its business strategies. The reader is referred to the Company’s public disclosure record which is available on SEDAR+ (sedarplus.ca). Although the Company believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except as required by securities laws and the policies of the TSX Venture Exchange, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

This news release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. No securities of the Company have been or will, in the foreseeable future, be registered under the United States Securities Act of 1933 (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

Initial engineering evaluates 20,000 tonnes of annual nickel production as the first
phase of a broader critical minerals processing facility

TORONTO, Sept. 16, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in North American critical minerals processing, today announced preliminary engineering results for the initial phase of a proposed two-phase nickel refinery to process mine-derived feedstock and recycled battery black mass into nickel metal and battery-grade nickel sulfate. The proposed facility would strengthen North American supply chains by supplying nickel for industrial, military and battery applications, helping reduce reliance on foreign processing.

The preliminary engineering study (FEL-1) evaluates the first-phase conversion of mine-derived feedstock into battery-grade nickel sulfate at a production capacity of approximately 20,000 tonnes per year of contained nickel. Preliminary process modelling indicates nickel and cobalt recoveries of 97% or higher, with recovered cobalt hydroxide providing a potential feedstock for Electra’s cobalt refinery.

“We need the capacity to refine nickel for industrial, military and battery applications,” said Trent Mell, CEO. “Electra is applying the expertise developed through our Ontario cobalt sulfate refinery and battery recycling work to advance a new source of nickel sulfate and nickel metal. Our goal is to strengthen critical mineral supply chains in the United States and Canada and reduce reliance on Chinese processing.”

The proposed facility would address a gap in North America’s capacity to convert nickel feedstock into products for domestic customers. Its intended product flexibility would serve both battery manufacturers requiring battery-grade nickel sulfate and industrial and military customers requiring nickel metal, including for aerospace applications.

The project is designed to establish capacity to process nickel intermediates that might otherwise be refined in China. By processing nickel closer to customers, the facility could help reduce exposure to geopolitical risk and strengthen the security and traceability of Western critical minerals supply chains.

Electra is advancing the financing and commercial strategy for this project in parallel with engineering. The Company continues to engage with governments on funding programs and with upstream and downstream partners on feedstock supply and offtake arrangements. These discussions are intended to align government support and private financing with the supply and customer commitments needed to develop competitive critical minerals processing capacity.

The proposed refinery would use conventional hydrometallurgical processes to refine feedstock from existing mining operations, drawing on Electra’s cobalt refining and battery recycling expertise. This approach would use available feedstock while creating a processing option for future domestic mine supply. The project relies primarily on established processing methods rather than the commercialization of new technology.

Preliminary capital estimates for the first-phase nickel sulfate refinery range from approximately US$530 million to US$675 million across the feedstock configurations evaluated, based on annual production of approximately 20,000 tonnes of contained nickel. Nickel metal production and the second-phase recycling expansion will require separate capital estimates.

A second phase could expand the facility to process battery black mass, with the potential to add an additional 20,000 tonnes per year of contained nickel capacity, along with cobalt, lithium and graphite byproducts. This expansion would build on Electra’s black mass demonstration work to recover critical minerals using hydrometallurgical processes. Recent U.S. restrictions on black mass exports underscore the need to limit critical minerals exports to support investment in domestic processing capacity.

Work completed to date includes preliminary process design, equipment sizing, site layout, infrastructure and logistics assessment, and capital and operating cost estimates. Further engineering is planned for nickel metal production to confirm product specifications, process scope and capital requirements.

The study uses a preferred location in the southeastern United States as its site basis. Final site selection remains subject to further assessment, as well as commercial and funding arrangements. Electra will continue to consider alternative locations in North America as it evaluates access to feedstock and customers, utilities, permitting requirements and the ability to accommodate the second-phase recycling expansion.

The next stage of work will focus on advancing site assessment and permitting planning alongside ongoing funding, feedstock and offtake discussions. As these parallel workstreams progress, Electra intends to refine equipment and utility requirements, effluent and tailings management plans, product specifications, and capital and operating cost estimates. Together, this work is expected to establish the site, feedstock and commercial basis required to advance the Project towards further engineering (FEL-3) and a potential development decision.

“Our focus is on securing the feedstock, customer commitments and financing needed to support a development decision,” said Mell. “We are working with governments and potential commercial partners to establish the conditions for a competitive North American nickel refinery serving industrial, military and battery customers.”

Electra’s immediate priority remains the completion and commissioning of its Ontario cobalt sulfate refinery. The proposed nickel refinery and recycling expansion remain longer-term opportunities.

About Electra Battery Materials

Electra is a leader in advancing North America’s critical minerals supply chain for lithium-ion batteries. The Company’s primary focus is constructing North America’s only cobalt sulfate refinery, as part of a phased strategy to onshore critical minerals refining and reduce reliance on foreign supply chains. In addition to the Refinery, Electra holds a significant land package in Idaho’s Cobalt Belt, including its Iron Creek project and surrounding properties, positioning the Company as a potential cornerstone for North American cobalt and copper production.

Electra is also advancing black mass recycling opportunities to recover critical materials from end-of-life batteries, while continuing to evaluate growth opportunities in nickel refining and other downstream battery materials. For more information, please visit www.ElectraBMC.com.

Contact
Heather Smiles
Vice President, External Affairs & Corporate Development
Electra Battery Materials
info@ElectraBMC.com
1.416.900.3891

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements and forward-looking information (together, “forward-looking statements”) within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. All statements, other than statements of historical facts, are forward-looking statements. Generally, forward-looking statements can be identified by the use of terminology such as “seek”, “expect”, “anticipate”, “budget”, “plan”, “estimate”, “continue”, “forecast”, “intend”, “believe”, “predict”, “potential”, “target”, “may”, “could”, “would”, “might”, “will” and similar words or phrases (including negative variations) suggesting future outcomes or statements regarding an outlook or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved” (including negative variations). Forward-looking statements in this release include, but are not limited to, statements regarding the advancement of a preliminary engineering study for a proposed nickel sulfate refinery; the evaluation of production levels from such a refinery, the identification of a suitable site for such a refinery; and discussions with potential financing and offtake partners. Forward-looking statements are based on the Company’s current beliefs and assumptions as to the outcome and timing of future events, including, but not limited to, that the anticipated timing for completion of engineering studies, the commercial viability of a nickel sulfate refinery in North America, the availability of government and commercial financing, and the ability to identify a suitable site for development. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results, performance and opportunities to differ materially from those implied by such forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, among other things: the commercial viability of a nickel sulfate refinery in North America, the availability of commercially feasible development sites, the negotiation of suitable supply and offtake arrangements with third-parties, the risks and uncertainties relating to commercial development; the need to comply with environmental and governmental regulations in Canada and the United States; fluctuations in the prices of commodities; operating hazards and risks; competition and other risks and uncertainties and other such factors as are set forth in the Annual Information Form, as well as the management discussion and analysis and other disclosures of risk factors for the Company, filed on SEDAR+ at www.sedarplus.com. Although the Company believes that the information and assumptions used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by applicable law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

VANCOUVER, British Columbia, Sept. 16, 2026 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | OTCQX:AMLIF | Frankfurt:5LA1) is pleased to report that the Falchani Lithium Project pilot-plant has all systems installed and operating. Recent laboratory testing has demonstrated an improvement in lithium recoveries. The pilot-plant, being advanced by TECMMINE in Lima, Peru, marks a key milestone toward derisking the Falchani project by validating the flowsheet at scale.

Highlights:

  • The pilot-plant is fully installed with the various components presently being tested with operating systems performing as expected.
  • Latest laboratory bench test work run using pilot plant equipment in a semi-continuous process achieved average lithium extraction of 88.7% (range: 88.0%–89.9%), well above the 80.0% recovery utilized in the February 2024 PEA. (1)
  • With all flow sheet equipment now installed and tested, the Company is advancing toward full end-to-end flowsheet validation – at scale in a continuous mode, to validate the bench-scale results.
  • The pilot-plant is expected to run continuously at target rates for 3+ months, processing 6–10 tonnes of Falchani mineralization.
  • Pilot plant results will feed into the future project feasibility work.

Dr. Laurence Stefan, President and COO, commented: “The results from the key core processing stages have been very encouraging. The consistency we are seeing gives us strong confidence as we move rapidly toward full pilot plant operations. Every stage we bring online has added to our understanding of how this deposit will perform at scale, optimizing to build on the promising recent results.”

The Company initially prioritized commissioning the plant’s core systems and are all operational and performing as expected. The key core systems are — impurity removal, controlled cooling, pre-neutralization, neutralization, crystallization, centrifugal separation, and consumables’ reaction management — all now individually validated. Recent laboratory bench test work that used individual components of the pilot-plant in a semi-continuous flow sheet (mainly crystallizers and evaporator) delivered very consistent results. Lithium losses across the alum crystallization, pre-neutralization, neutralization, mechanical evaporation, and precipitation stages were reduced to fractions of a percent per phase, driving the 88.7% overall lithium recovery, which is above the PEA recovery rate noted above. (1)

Falchani’s volcanic-hosted lithium mineralization has naturally low impurities, supporting a simple flowsheet capable of producing battery-grade lithium carbonate exceeding 99.5% purity.

American Lithium Corp.

Figure 1: Partial View of the Pilot Plant. More Images Here

Qualified Person

Mr. Ted O’Connor, P.Geo., a Director of American Lithium, and a Qualified Person as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed and approved the scientific and technical information contained in this news release.

About TECMMINE

TECMMINE E.I.R.L. is a Peruvian metallurgical consulting company based in Lima, Peru with mineral processing and metallurgical testing laboratory facilities and experienced metallurgical personnel led by Eng. Jose Malqui.

About American Lithium

American Lithium is developing two of the world’s largest, advanced-stage lithium projects, along with the largest undeveloped uranium project in Latin America. They include the TLC claystone lithium project in Nevada and the Falchani hard-rock lithium project in southern Peru, which also hosts a globally significant cesium resource, as well as the Macusani uranium project located in the same region. All three projects have completed robust preliminary economic assessments, exhibit significant expansion potential and enjoy strong community support.

For more information, please contact the Company at info@americanlithiumcorp.com or visit our website at www.americanlithiumcorp.com.

Follow us on Facebook, Twitter and LinkedIn.

On behalf of the Board of Directors of American Lithium Corp.

“Alex Tsakumis”

Chief Executive Officer

Tel: 604 428 6128

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

(1)Cautionary Note Regarding PEA
Certain technical information in this News Release refers to the results of the PEA prepared for the Project. PEAs are preliminary in nature and include inferred mineral resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves. There is no certainty the results of the PEA’s will be realized. Mineral resources are not mineral reserves and do not have demonstrated economic viability. Additional work is required to upgrade the mineral resources to mineral reserves. In addition, the mineral resource estimates could be materially affected by environmental, geotechnical, permitting, legal, title, taxation, socio-political, marketing, or other relevant factors.

Cautionary Statement Regarding Forward Looking Information
This news release contains certain forward-looking information and forward-looking statements (collectively “forward-looking statements”) within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements in this news release include, but are not limited to, statements regarding the business plans, expectations and objectives of American Lithium. Forward-looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend”, “indicate”, “scheduled”, “target”, “goal”, “potential”, “subject”, “efforts”, “option” and similar words, or the negative connotations thereof, referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management and are not, and cannot be, a guarantee of future results or events. Although American Lithium believes that the current opinions and expectations reflected in such forward-looking statements are reasonable based on information available at the time, undue reliance should not be placed on forward-looking statements since American Lithium can provide no assurance that such opinions and expectations will prove to be correct. All forward-looking statements are inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including risks, uncertainties and assumptions related to: American Lithium’s ability to achieve its stated goals;, which could have a material adverse impact on many aspects of American Lithium’s businesses including but not limited to: the ability to access mineral properties for indeterminate amounts of time, the health of the employees or consultants resulting in delays or diminished capacity, social or political instability in Peru which in turn could impact American Lithium’s ability to maintain the continuity of its business operating requirements, may result in the reduced availability or failures of various local administration and critical infrastructure, reduced demand for the American Lithium’s potential products, availability of materials, global travel restrictions, and the availability of insurance and the associated costs; the ongoing ability to work cooperatively with stakeholders, including but not limited to local communities and all levels of government; the potential for delays in exploration or development activities; the interpretation of drill results, the geology, grade and continuity of mineral deposits; the possibility that any future exploration, development or mining results will not be consistent with our expectations; risks that permits will not be obtained as planned or delays in obtaining permits; mining and development risks, including risks related to accidents, equipment breakdowns, labour disputes (including work stoppages, strikes and loss of personnel) or other unanticipated difficulties with or interruptions in exploration and development; risks related to commodity price and foreign exchange rate fluctuations; risks related to foreign operations; the cyclical nature of the industry in which American Lithium operates; risks related to failure to obtain adequate financing on a timely basis and on acceptable terms or delays in obtaining governmental approvals; risks related to environmental regulation and liability; political and regulatory risks associated with mining and exploration; risks related to the uncertain global economic environment and the effects upon the global market generally, any of which could continue to negatively affect global financial markets, including the trading price of American Lithium’s shares and could negatively affect American Lithium’s ability to raise capital and may also result in additional and unknown risks or liabilities to American Lithium. Other risks and uncertainties related to prospects, properties and business strategy of American Lithium are identified in the “Risk Factors” section of American Lithium’s Management’s Discussion and Analysis filed on July 30, 2026, and in recent securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements. American Lithium undertakes no obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/48f7ceb5-b758-4abc-be22-054246720555

MONTREAL, Sept. 16, 2026 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; NASDAQ: AYA) (“Aya” or the “Company”) is pleased to announce high-grade silver drill results from its at-depth drill exploration program at the Zgounder Silver Mine (“Zgounder”) in the Kingdom of Morocco.

Highlights (all intersections are in core lengths)

  • Intersections in the Open-Pit Area:
    • Hole ZG-RC-24-155 intercepted 783 grams per tonne (“g/t”) silver (“Ag”) over 13.0 metres (“m”)
    • Hole ZG-RC-24-354 intercepted 501 g/t Ag over 11.0m, including 4,000 g/t over 1.0m
    • Hole ZG-SF-25-702 intercepted 1,553 g/t Ag over 1.4m
  • Intersections in the Central Area:
    • Hole DZG-SF-26-945 intercepted 3,501 g/t Ag over 3.5m, including 7,717 g/t Ag over 1.5m
    • Hole T28-26-1334 intercepted 4,770 g/t Ag over 2.4m
    • Hole T28-26-1333 intercepted 1,362 g/t Ag over 8.4m, including 2,873 g/t Ag over 3.6m
    • Hole T28-26-1404 intercepted 762 g/t Ag over 12.0m
  • 16,217m or 54.1% of the 2026 exploration program has been drilled year to date.

“Today’s high-grade results, highlighted by DZG-SF-26-945, continue to reinforce the strength and continuity of silver mineralization both around the open pit and across the central zone,” said Benoit La Salle, President & CEO. “At the same time, development of the exploration drift at the 1,825-metre level is progressing well, setting the stage for drilling west of the fault to begin in Q4 and providing an important new opportunity to expand the mineralized footprint.”

This release contains results from 97 holes, which include one surface diamond drill holes (“DDH”), 31 underground DDH, seven reverse circulation drill hole (“RC”), 45 T28 and 13 YAK holes (T28 and YAK: percussion drilling using an air-compressed hammer). For a full summary of today’s results, refer to Appendix 1 and 2.

Table 1 – Best Intercepts at Zgounder (core lengths)

Hole ID From To Ag Length* Ag x width
(g/t) (m)  
Underground DDH
DZG-SF-25-702 58.3 59.7 1,553 1.4 2,174
DZG-SF-25-789 18.5 21.0 760 2.5 1,901
DZG-SF-26-885 124.0 125.0 1,503 1.0 1,503
DZG-SF-26-898 109.5 111.0 1,208 1.5 1,812
DZG-SF-26-943 34.5 36.0 874 1.5 1,311
DZG-SF-26-945 16.0 19.5 3,501 3.5 12,254
Including 16.5 18.0 7,717 1.5 11,575
Surface RC
ZG-RC-24-155 0.0 13.0 783 13.0 10,180
ZG-RC-24-354 2.0 13.0 501 11.0 5,512
Including 6.0 7.0 4,000 1.0 4,000
Underground T28
T28-26-1325 0.0 9.6 302 9.6 2,903
T28-26-1333 9.6 18.0 1,362 8.4 11,437
Including 9.6 13.2 2,873 3.6 10,344
T28-26-1334 24.0 26.4 4,770 2.4 11,448
T28-26-1335 13.2 15.6 1,603 2.4 3,846
T28-26-1358 16.8 24.0 450 7.2 3,242
T28-26-1401 7.2 15.6 258 8.4 2,164
T28-26-1404 7.2 19.2 762 12.0 9,149
T28-26-1420 3.6 26.4 297 22.8 6,775
Including 3.6 14.4 382 10.8 4,128
T28-26-1441 18.0 25.2 403 7.2 2,898
Including 21.6 25.2 695 3.6 2,501
T28-26-1443 14.4 25.2 468 10.8 5,050
Including 14.4 16.8 1,168 2.4 2,802
T28-26-1447 7.2 18.0 232 10.8 2,506
T28-26-1448 19.2 24.0 450 4.8 2,158
Underground YAK
YAK-26-554 12.0 15.6 1,670 3.6 6,012
YAK-26-571 9.6 13.2 606 3.6 2,182
YAK-26-575 33.6 36.0 1,715 2.4 4,116

Figure 1 Location of Drill Results at Zgounder

Figure 1: Location of Drill Results at Zgounder

Quality Assurance

For core drilling, all individual samples represent approximately one meter in length of core, which is halved. Half of the core is kept on site for reference, and its counterpart is sent for preparation and assaying to African Laboratory for Mining and Environment (“Afrilab”) in Marrakech, Morocco or to ALS Laboratory at the Zgounder Mine site. All samples are analyzed for silver, copper, iron, lead, and zinc using Aqua regia and finished by atomic absorption spectroscopy (“AAS”). Samples grading above 200 g/t Ag are reanalyzed by fire assay.

For definition drilling using RC, all individual samples represent 1.0m in length and for T28 drilling equipment, all individual samples represent 1.2m in length. Samples are assayed at either the ALS Mine laboratory or at Afrilab. All samples are analyzed for silver, copper, iron, lead, and zinc using Aqua regia and finished by AAS. Samples grading above 200 g/t Ag are reanalyzed by fire assay. Rigorous quality controls (QaQc) are applied at both locations.

Qualified Person

The scientific and technical information contained in this press release has been reviewed, verified and approved by David Lalonde, B. Sc, P. Geo, Executive Vice-President, Exploration, Qualified Person, for accuracy and compliance with National Instrument 43-101.

About Aya Gold & Silver Inc.

Aya Gold & Silver is a Canadian precious metals mining company anchored in Morocco and active across the full mining value chain. The Company has established an exploration track record through a systematic, technology-led, data-driven approach and is focused on expanding its resource base and land package along the Anti-Atlas fault — one of Africa’s most geologically rich, underexplored and mining-friendly regions.

Aya operates Zgounder, a rare, silver-only mine, producing silver doré from its new processing facility. Aya’s growth pipeline includes the Boumadine polymetallic project, where feasibility study work is underway, and which hosts a sizable mineralized footprint, and potential for further discovery.

Led by a proven team of mining professionals, Aya is guided by a vision of responsible mining and is committed to delivering sustainable value for shareholders, employees and host communities.

For additional information, please visit Aya’s website at www.ayagoldsilver.com.

Or contact

Benoit La Salle, FCPA, MBA Alex Ball
President & CEO Executive Vice-President, Capital Markets
benoit.lasalle@ayagoldsilver.com alex.ball@ayagoldsilver.com


Forward-Looking Statement 

This press release contains “forward-looking statements” or “forward-looking information” within the meaning of applicable securities laws and other statements that are not historical facts. Forward-looking statements are included to provide information about management’s current expectations, estimates and projections regarding Aya’s future growth and business prospects (including the timing and development of deposits and the success of exploration activities) and other opportunities as of the date of this press release.

All statements, other than statements of historical fact included in this press release, regarding the Company’s strategy, future operations, technical assessments, prospects, plans and objectives of management are forward-looking statements that involve risks and uncertainties. Wherever possible, words such as “aim”, “anticipate”, “assume”, “believe”, “estimate”, “expect”, “goal”, “guidance”, “intend”, “objective”, “plan”, “potential”, “strategy”, “target”, and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might”, “will”, or are “likely” to be taken, occur or be achieved, have been used to identify such forward-looking information. Forward-looking statements in this press release include, but are not limited to, statements with respect to: the 2026 exploration program; the timing and commencement of drilling west of the fault at Zgounder; and the potential expansion of the mineralized footprint at Zgounder.

Forward-looking information is based upon certain assumptions and other important factors that, if untrue, could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such information or statements. There can be no assurance that such information or statements will prove to be accurate. Key assumptions upon which the Company’s forward-looking information is based include without limitation, assumptions regarding development and exploration activities; the Company’s ability to execute its business plans and objectives; the ability to commence and successfully execute planned drilling and exploration activities; the accuracy of the Company’s geological interpretations and the continuity of mineralization in areas targeted for exploration; the continued validity and good standing of the mining titles necessary to conduct the planned exploration activities; the timely receipt of necessary approvals or permits; the ability to obtain timely financing on reasonable terms when required; future social, economic and political conditions remaining consistent with those currently prevailing; the availability of qualified contractors, consultants, suppliers, equipment, materials and labour on commercially reasonable terms; and the cooperation of government authorities, municipalities and other stakeholders.

Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions which may have been used. Forward-looking statements are also subject to risks and uncertainties facing the Company’s business, any of which could have a material adverse effect on the Company’s business, financial condition, results of operations and growth prospects. Some of the risks the Company faces and the uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements include, among others: Aya’s ability to execute on its plans relating to the Zgounder Project, including the timing thereof; delays in the development of the exploration drift or in accessing areas targeted for drilling; delays in the commencement or completion of planned drilling and exploration activities; the risk that exploration results may not be indicative of future results; risks and hazards associated with the business of mineral exploration, development and mining, including environmental hazards, potential unintended releases of contaminants, industrial accidents, unusual or unexpected geological or structural formations, pressures, cave-ins, and flooding; risks related to Aya’s operations in Morocco; the speculative nature of mineral exploration and development; inadequate or unreliable infrastructure (such as roads, bridges, power sources and water supplies); fluctuations in forward markets for silver and other commodities (such as natural gas, fuel, oil and electricity); availability of gas, fuel and oil; restrictions on mining in the jurisdictions in which Aya operates; changes in laws and regulations governing our operations, exploration, and development activities, including international laws and legal norms; the potential impact of future pandemics or epidemics on the Company’s operations, and assumptions related thereto; Aya’s ability to attract and retain qualified employees and contractors; Aya’s ability to obtain and renew necessary permits and licences; Aya’s ability to obtain and maintain insurance; occupational health and safety risks; adverse publicity risks; third-party risks; disruptions to Aya’s business operations; Aya’s reliance on technology and information systems; unforeseen expenses; public health crises; climate change; weather disruptions; general economic conditions; force majeure; the inherent risks involved in exploration and development of mineral properties; and other risks described in the Company’s documents filed with Canadian and U.S. securities regulatory authorities.

In addition, readers are directed to carefully review the detailed risk discussion in the Company’s Annual Information Form and Management’s Discussion & Analysis for the year ended December 31, 2025, filed on SEDAR+ and on EDGAR, which discussions are incorporated by reference in this press release, for a fuller understanding of the risks and uncertainties that affect the Company’s business and operations.

Although the Company believes its expectations are based upon reasonable assumptions and has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. As such, these risks are not exhaustive; however, they should be considered carefully. If any of these risks or uncertainties materialize, actual results may vary materially from those anticipated in the forward-looking statements found herein. Due to the risks, uncertainties, and assumptions inherent in forward-looking statements, readers should not place undue reliance on forward-looking statements.

Forward-looking statements contained herein are presented for the purpose of assisting investors in understanding the Company’s business plans, financial performance and condition and may not be appropriate for other purposes.

The forward-looking statements contained herein are made only as of the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law. The Company qualifies all of its forward-looking statements by these cautionary statements.

Appendix 1 – Mineral Intercepts from Drilling at Zgounder (core lengths)

Hole ID From To Ag Length* Ag x width
(g/t) (m)  
Surface DDH
ZG-26-211 537.0 538.0 645 1.0 645
Underground DDH
ZG-26-211 537.0 538.0 645 1.0 645
ZG-SF-26-361 135.0 136.0 358 1.0 358
ZG-SF-26-361 155.0 157.0 147 2.0 294
ZG-SF-26-361 170.0 174.0 268 4.0 1,071
ZG-SF-TS-26-008A 31.0 31.5 220 0.5 110
ZG-SF-TS-26-008A 50.5 52.0 172 1.5 258
DZG-SF-25-702 58.3 59.7 1,553 1.4 2,174
DZG-SF-25-708 46.9 48.0 356 1.1 392
DZG-SF-25-727 0.0 1.7 108 1.7 183
DZG-SF-25-771 30.5 32.0 240 1.5 360
DZG-SF-25-773 26.0 27.5 388 1.5 582
DZG-SF-25-789 2.5 3.5 561 1.0 561
DZG-SF-25-789 18.5 21.0 760 2.5 1,901
DZG-SF-26-829 6.5 8.0 136 1.5 204
DZG-SF-26-871 72.0 73.5 288 1.5 432
DZG-SF-26-879 56.0 57.0 104 1.0 104
DZG-SF-26-884 81.0 82.1 212 1.1 233
DZG-SF-26-885 124.0 125.0 1,503 1.0 1,503
DZG-SF-26-886 45.5 46.0 364 0.5 182
DZG-SF-26-891 42.0 43.5 83 1.5 125
DZG-SF-26-895 56.5 57.5 206 1.0 206
DZG-SF-26-898 109.5 111.0 1,208 1.5 1,812
DZG-SF-26-899 31.0 32.0 384 1.0 384
DZG-SF-26-900 30.5 31.5 1,147 1.0 1,147
DZG-SF-26-904 30.0 33.0 111 3.0 333
DZG-SF-26-910 33.0 34.5 121 1.5 182
DZG-SF-26-912 95.0 96.5 291 1.5 436
DZG-SF-26-916 116.0 119.5 252 3.5 881
DZG-SF-26-916 138.0 139.0 79 1.0 79
DZG-SF-26-922 32.0 33.0 77 1.0 77
DZG-SF-26-922 37.0 42.0 229 5.0 1,144
DZG-SF-26-928 3.8 5.3 212 1.5 318
DZG-SF-26-933 75.0 76.0 759 1.0 759
DZG-SF-26-933 91.0 92.0 651 1.0 651
DZG-SF-26-943 1.0 1.8 93 0.8 74
DZG-SF-26-943 4.5 6.0 107 1.5 161
DZG-SF-26-943 7.5 9.0 106 1.5 159
DZG-SF-26-943 29.5 30.0 94 0.5 47
DZG-SF-26-943 34.5 36.0 874 1.5 1,311
DZG-SF-26-944 12.5 13.5 82 1.0 82
DZG-SF-26-944 42.3 43.5 141 1.2 169
DZG-SF-26-945 10.1 11.5 506 1.4 708
DZG-SF-26-945 16.0 19.5 3,501 3.5 12,254
Including 16.5 18.0 7,717 1.5 11,575
DZG-SF-26-945 21.0 22.5 101 1.5 152
DZG-SF-26-946 4.5 6.0 89 1.5 134
DZG-SF-26-946 81.5 83.0 290 1.5 435
DZG-SJ-CD-26-028 49.0 50.0 99 1.0 99
DZG-SJ-CD-26-028 51.0 52.0 123 1.0 123
Surface RC
ZG-RC-24-155 0.0 13.0 783 13.0 10,180
ZG-RC-24-250 72.0 73.0 680 1.0 680
ZG-RC-24-354 2.0 13.0 501 11.0 5,512
Including 6.0 7.0 4,000 1.0 4,000
ZG-RC-24-421 0.0 3.0 143 3.0 428
ZG-RC-25-412 50.0 51.0 824 1.0 824
ZG-RC-26-1046 17.0 19.0 102 2.0 203
ZG-RC-26-1054 24.0 25.0 150 1.0 150
Underground T28
T28-26-1310 14.4 16.8 682 2.4 1,636
T28-26-1311 7.2 9.6 100 2.4 239
T28-26-1312 21.6 24.0 97 2.4 233
T28-26-1324 0.0 3.6 174 3.6 628
T28-26-1325 0.0 9.6 302 9.6 2,903
T28-26-1332 10.8 13.2 537 2.4 1,289
T28-26-1332 16.8 18.0 116 1.2 139
T28-26-1333 9.6 18.0 1,362 8.4 11,437
Including 9.6 13.2 2,873 3.6 10,344
T28-26-1334 9.6 16.8 260 7.2 1,872
T28-26-1334 24.0 26.4 4,770 2.4 11,448
T28-26-1335 13.2 15.6 1,603 2.4 3,846
T28-26-1357 18.0 19.2 77 1.2 92
T28-26-1358 16.8 24.0 450 7.2 3,242
T28-26-1361 21.6 24.0 151 2.4 362
T28-26-1382 0.0 1.2 151 1.2 181
T28-26-1389 9.6 13.2 88 3.6 318
T28-26-1392 0.0 4.8 267 4.8 1,282
T28-26-1401 7.2 15.6 258 8.4 2,164
Including 7.2 10.8 483 3.6 1,739
T28-26-1402 2.4 4.8 111 2.4 265
T28-26-1403 7.2 10.8 109 3.6 391
T28-26-1404 7.2 19.2 762 12.0 9,149
T28-26-1405 19.2 21.6 87 2.4 208
T28-26-1406 10.8 13.2 193 2.4 462
T28-26-1407 9.6 12.0 193 2.4 463
T28-26-1410 4.8 6.0 80 1.2 96
T28-26-1411 7.2 9.6 252 2.4 605
T28-26-1411 10.8 12.0 90 1.2 108
T28-26-1412 3.6 9.6 168 6.0 1,008
T28-26-1413 9.6 10.8 85 1.2 102
T28-26-1414 0.0 4.8 295 4.8 1,414
T28-26-1415 0.0 3.6 133 3.6 479
T28-26-1415 9.6 10.8 116 1.2 139
T28-26-1415 14.4 16.8 314 2.4 754
T28-26-1418 18.0 19.2 155 1.2 186
T28-26-1419 4.8 6.0 77 1.2 92
T28-26-1419 8.4 9.6 117 1.2 140
T28-26-1419 13.2 14.4 132 1.2 158
T28-26-1419 15.6 20.4 159 4.8 763
T28-26-1419 25.2 26.4 216 1.2 259
T28-26-1420 3.6 26.4 297 22.8 6,775
Including 3.6 14.4 382 10.8 4,128
T28-26-1422 10.8 12.0 95 1.2 114
T28-26-1425 19.2 21.6 114 2.4 272
T28-26-1441 18.0 25.2 403 7.2 2,898
Including 21.6 25.2 695 3.6 2,501
T28-26-1442 0.0 1.2 553 1.2 664
T28-26-1442 21.6 24.0 163 2.4 390
T28-26-1443 7.2 8.4 80 1.2 96
T28-26-1443 10.8 12.0 89 1.2 107
T28-26-1443 14.4 25.2 468 10.8 5,050
Including 14.4 16.8 1,168 2.4 2,802
T28-26-1444 13.2 15.6 90 2.4 216
T28-26-1444 19.2 22.8 271 3.6 974
T28-26-1447 7.2 18.0 232 10.8 2,506
Including 14.4 18.0 444 3.6 1,598
T28-26-1448 16.8 18.0 108 1.2 130
T28-26-1448 19.2 24.0 450 4.8 2,158
T28-26-1449 19.2 20.4 87 1.2 104
T28-26-1450 7.2 8.4 79 1.2 95
T28-26-1450 16.8 19.2 134 2.4 322
T28-26-1451 19.2 20.4 195 1.2 234
T28-26-1463 9.6 15.6 130 6.0 780
T28-26-1464 9.6 14.4 154 4.8 738
T28-26-1466 13.2 15.6 283 2.4 679
Underground YAK
YAK-26-503 4.8 6.0 599 1.2 719
YAK-26-515 8.4 10.8 82 2.4 196
YAK-26-515 13.2 14.4 166 1.2 199
YAK-26-520 4.8 6.0 240 1.2 288
YAK-26-553 3.6 4.8 101 1.2 121
YAK-26-553 8.4 9.6 126 1.2 151
YAK-26-553 10.8 12.0 191 1.2 229
YAK-26-553 43.2 44.4 83 1.2 100
YAK-26-554 12.0 15.6 1,670 3.6 6,012
YAK-26-561 46.8 48.0 77 1.2 92
YAK-26-562 0.0 1.2 86 1.2 103
YAK-26-563 1.2 2.4 266 1.2 319
YAK-26-568 48.0 49.2 113 1.2 136
YAK-26-571 9.6 13.2 606 3.6 2,182
YAK-26-572 6.0 10.8 152 4.8 728
YAK-26-572 44.4 45.6 92 1.2 110
YAK-26-575 33.6 36.0 1,715 2.4 4,116
YAK-26-581 28.8 32.4 318 3.6 1,144

True widths are undetermined; all values are uncut.

Appendix 2 – Drill Hole Coordinates of Zgounder Drill Hole with Significant Results

Hole ID Easting Northing Elevation Azimuth Dip Length (m)
Surface DDH
ZG-26-211 620442 3403648 2076 0 -75 564
Underground DDH
ZG-SF-26-361 620832 3403979 1969 180 -86 216
ZG-SF-TS-26-008A 620529 3403908 1919 170 -63 74
DZG-SF-25-702 621211 3404043 2073 65 16 80
DZG-SF-25-708 621212 3404040 2072 98 -14 65
DZG-SF-25-727 620983 3404059 1969 5 36 65
DZG-SF-25-771 620554 3404007 1909 72 -30 100
DZG-SF-25-773 620554 3404007 1909 72 0 90
DZG-SF-25-789 620549 3404009 1908 338 -30 80
DZG-SF-26-829 621127 3404082 2020 27 22 60
DZG-SF-26-871 620700 3403985 1885 56 -6 150
DZG-SF-26-879 620918 3404096 1997 267 3 60
DZG-SF-26-884 620793 3404090 1937 268 0 135
DZG-SF-26-885 620793 3404088 1937 259 0 132
DZG-SF-26-886 620918 3404098 1996 289 -11 60
DZG-SF-26-891 620429 3404008 1945 323 2 150
DZG-SF-26-895 620437 3404006 1945 80 4 60
DZG-SF-26-898 620767 3404056 1912 83 0 150
DZG-SF-26-899 620766 3404057 1912 72 -10 150
DZG-SF-26-900 620766 3404057 1912 72 0 134
DZG-SF-26-904 620761 3404058 1912 330 0 150
DZG-SF-26-910 620759 3404054 1912 278 -10 150
DZG-SF-26-912 620801 3404090 1937 60 0 150
DZG-SF-26-916 620793 3404087 1937 259 -10 150
DZG-SF-26-922 620801 3404089 1937 97 -10 150
DZG-SF-26-928 621087 3404093 1973 109 -21 75
DZG-SF-26-933 621080 3404095 1973 298 -1 95
DZG-SF-26-943 621055 3404053 1941 330 0 150
DZG-SF-26-944 621054 3404052 1941 315 0 150
DZG-SF-26-945 621052 3404051 1941 299 0 150
DZG-SF-26-946 621080 3404095 1974 299 14 95
DZG-SJ-CD-26-028 621286 3404887 2205 135 -60 59
Surface RC
ZG-RC-24-155 621245 3404121 2234 180 -72 124
ZG-RC-24-250 621158 3404095 2222 180 -70 74
ZG-RC-24-354 621033 3404068 2228 180 -70 80
ZG-RC-24-421 621033 3404093 2223 135 -70 50
ZG-RC-25-412 621052 3404094 2222 135 -70 55
ZG-RC-26-1046 621206 3404141 2201 135 -71 60
ZG-RC-26-1054 621187 3404125 2201 135 -70 50
Underground T28
T28-26-1310 621054 3404106 2027 82 10 26
T28-26-1311 621054 3404106 2027 82 25 26
T28-26-1312 621057 3404101 2027 99 13 26
T28-26-1324 620602 3403990 1909 183 12 26
T28-26-1325 620602 3403990 1909 179 21 25
T28-26-1332 620633 3403997 1909 68 9 23
T28-26-1333 620633 3403997 1910 68 21 22
T28-26-1334 620622 3404019 1910 120 8 26
T28-26-1335 620622 3404019 1910 120 20 26
T28-26-1357 620636 3404087 2000 360 14 26
T28-26-1358 620632 3404087 2001 348 19 26
T28-26-1361 620651 3404077 1998 219 5 26
T28-26-1382 620768 3404040 2023 358 15 25
T28-26-1389 620602 3404045 1910 136 9 19
T28-26-1392 620597 3404046 1910 338 9 12
T28-26-1401 620896 3404033 2002 67 5 26
T28-26-1402 620896 3404033 2002 85 20 26
T28-26-1403 620896 3404035 2002 58 5 26
T28-26-1404 620896 3404035 2002 58 20 24
T28-26-1405 620895 3404038 2002 46 5 26
T28-26-1406 620894 3404038 2002 40 20 25
T28-26-1407 620893 3404040 2002 30 5 19
T28-26-1410 620890 3404040 2003 358 20 12
T28-26-1411 620888 3404040 2003 325 5 26
T28-26-1412 620888 3404040 2003 323 20 26
T28-26-1413 620887 3404039 2002 308 5 13
T28-26-1414 620887 3404039 2003 311 20 26
T28-26-1415 620886 3404038 2002 319 5 17
T28-26-1418 620884 3404036 2003 271 20 26
T28-26-1419 620888 3404033 2002 255 5 26
T28-26-1420 620888 3404034 2002 256 20 26
T28-26-1422 620890 3404032 2002 230 20 19
T28-26-1425 620670 3404005 1910 66 5 25
T28-26-1441 620965 3404113 1995 271 5 25
T28-26-1442 620965 3404113 1995 271 13 24
T28-26-1443 620964 3404119 1995 273 6 25
T28-26-1444 620964 3404119 1995 268 11 25
T28-26-1447 620973 3404117 1995 94 10 26
T28-26-1448 620966 3404130 1995 92 7 24
T28-26-1449 620973 3404111 1995 92 16 26
T28-26-1450 620973 3404117 1995 91 17 22
T28-26-1451 620966 3404130 1995 90 21 26
T28-26-1463 620492 3404058 1909 253 10 22
T28-26-1464 620490 3404048 1911 255 5 23
T28-26-1466 620519 3404045 1910 122 20 26
Underground YAK
YAK-26-503 620401 3404064 1956 268 11 50
YAK-26-515 620424 3404105 1955 108 28 31
YAK-26-520 620384 3404089 1954 278 10 50
YAK-26-553 620888 3404131 2023 290 5 49
YAK-26-554 620891 3404136 2023 302 5 50
YAK-26-561 620903 3404135 2023 103 5 50
YAK-26-562 620897 3404130 2023 110 5 50
YAK-26-563 620897 3404130 2023 110 22 50
YAK-26-568 620900 3404140 2023 5 15 50
YAK-26-571 620891 3404136 2023 302 15 50
YAK-26-572 620888 3404131 2023 290 15 49
YAK-26-575 621081 3404068 2028 121 6 36
YAK-26-581 621081 3404075 2028 72 19 32

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fe3e0d90-df72-40f8-b1a1-22762834fbf0

The Supervisory Board of Coop Pank AS has elected Moonika Maaring, currently Head of Everyday Banking in the Private Clients segment at Coop Pank, as a new member of the bank’s Management Board. Her term of office as Head of Retail Banking and Member of the Management Board will commence on 1 November 2026 and will last for three years.

Moonika Maaring was also elected as a member of the Supervisory Boards of Coop Pank AS subsidiaries Coop Liising AS and Coop Kindlustusmaakler AS. Her terms of office in these roles will also commence on 1 November 2026 and will last for three years.

According to Arko Kurtmann, Chairman of the Management Board of Coop Pank, appointing a new Management Board member from within the bank helps ensure continuity and build on the bank’s progress to date.

“It is important to us that we can provide our people with opportunities to grow and take on greater responsibility within the organisation. Moonika Maaring knows both our bank and our customers well and has extensive experience in the Estonian banking sector. Moonika’s in-depth understanding of retail banking and its development gives us confidence that she will excel in her role as a member of the Management Board and contribute to Coop Pank’s continued development,” said Kurtmann.

Moonika Maaring holds a degree in International Business Administration from EBS, with a specialisation in marketing. She has extensive management experience in banking, insurance, sales and service processes, customer experience, and product and service development.

Maaring joined Coop Pank on 1 April 2024. Prior to that, she served as Head of Retail Banking at LHV Pank and held various other management positions. She has previously worked at Swedbank P&C Insurance and Salva Kindlustus.

Moonika Maaring holds 52,400 Coop Pank share options but does not own any shares or bonds of Coop Pank.

Karel Parve, the current Head of Retail Banking and Member of the Management Board of Coop Pank, announced in August that he would not seek an extension of his term of office upon its expiry. His term of office will expire as scheduled on 31 October 2026.

The Management Board of Coop Pank consists of six members: Chairman of the Management Board Arko Kurtmann, Chief Financial Officer Paavo Truu, Chief Risk Officer Heikko Mäe, Chief Information Officer Alvar Pihlapuu, Head of Corporate Banking Lehar Kütt, and Head of Retail Banking Karel Parve, whose term of office will expire on 31 October 2026. From 1 November 2026, Moonika Maaring will serve as Head of Retail Banking and Member of the Management Board.

Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The bank has 239,100 clients who use everyday banking services. Coop Pank uses the synergy created between retail trade and banking and brings everyday banking solutions closer to people. The majority shareholder of the Bank is a domestic retail chain Coop Eesti, the sales network of which comprises over 330 stores.

Additional information:
Ave Tammeniit
Communications Manager
Coop Pank AS
Phone: +372 5887 4828
Email: ave.tammeniit@cooppank.ee

CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.

Company Webcast

The webcast presentation will take place at 11:45 a.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/lJ5aBmzWwkZ. The webcast will also be available for replay following the event.

1×1 Meetings

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/fall2026invreg/.   

About NeurAxis, Inc.

NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive the adoption of IB-Stim, its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is FDA-cleared for functional abdominal pain in irritable bowel syndrome (IBS) and functional dyspepsia, including FD-linked nausea symptoms in patients ages 8 and older. Additional clinical trials of PENFS in multiple pediatric and adult conditions with large unmet healthcare needs are underway. For more information, please visit http://neuraxis.com.

Contacts:

Company
NeurAxis, Inc.
info@neuraxis.com

Investor Relations
Lytham Partners
Ben Shamsian
646-829-9701
shamsian@lythampartners.com

Limited-Edition Candy Corn Wheat Ale Craft Beer and Spirit Halloween-Exclusive Wedgehead Costume Bring Big Flavor, Big Fun, and Head-Turning Halloween Energy to Fans Nationwide

Shock Top Candy Corn Wheat

PORTLAND, Ore., Sept. 16, 2026 (GLOBE NEWSWIRE) — Shock Top, the shockingly refreshing craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), known for its bold flavors and unfiltered wheat ales, has teamed up with Spirit, North America’s premier Halloween retailer, for a limited-edition collaboration that’s spilling two must-have treats for spooky season: the all-new Shock Top Candy Corn Wheat Ale and a Wedgehead Costume, exclusively at Spirit Halloween. Inspired by the season that brings parties to life, the collaboration invites fans to sip, suit up, and celebrate Halloween with a little more flavor – and a lot more fun.

The collaboration debuts Shock Top Candy Corn Wheat, a limited-edition beer inspired by the playful spirit and larger-than-life energy that Spirit Halloween brings to fans every fall. Blending Shock Top’s signature wheat beer with the unmistakable flavor of Halloween’s most iconic candy, the 5% ABV, seasonal release is brewed for costume parties, haunted gatherings, and celebrating spooky season one sip at a time.

“Shock Top is known for celebrating bold flavor, spirited gatherings and moments that catch people by surprise, and there’s no better occasion for that than Halloween,” said Jacob Neilson, Senior Brand Manager at Shock Top. “Partnering with Spirit – the most iconic name in Halloween – gave us the chance to dream up something hauntingly good that celebrates everything fans love about the season.”

If Spirit Halloween is where fans become their favorite characters, this year they’ll have the chance to step into the iconic orange slice of one of beer’s most recognizable mascots. Available exclusively online at SpiritHalloween.com, the all-new Wedgehead Costume transforms Shock Top’s legendary mascot into an easy-to-wear jumpsuit (SRP: $69.99) that’s perfect for Halloween parties, bar crawls, costume contests, and anyone looking to squeeze a little extra personality into spooky season.

“Spirit fans don’t just celebrate Halloween; they live for it, and we’re always looking for new ways to surprise them,” said Kym Sarkos, Executive Vice Present, General Merchandise Manager at Spirit Halloween. “Pairing the launch of Shock Top’s Candy Corn Wheat Ale with our exclusive Wedgehead costume delivers the exact kind of head-turning, unexpected fun our fans are obsessed with.”

Shock Top Costumes

The limited-edition beer and exclusive costume bring together two brands that know how to make the season more memorable. Shock Top Candy Corn Wheat is available at retailers nationwide, and the iconic Wedgehead costume is available on spirithalloween.com.

Follow @shocktop and @spirithalloween on social for more seasonal sips, scares, and surprises.

About Shock Top
Shock Top is a bold, Belgian-style wheat ale brand known for its refreshing taste, citrus-forward character, and easygoing personality. Crafted to bring unexpected flavor and energy to every occasion, Shock Top has become a go-to choice for beer drinkers looking for something expressive, approachable, and fun. Shock Top is part of the Tilray Beverages portfolio.

About Tilray Brands
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

About Spirit Halloween
Spirit Halloween is the largest Halloween retailer in North America. With over 1,550 seasonal locations now open across North America, Spirit is the one-stop destination for all things Halloween. For more than four decades, Spirit has created immersive and interactive experiences for shoppers, complete with a unique and vast assortment of costumes and accessories for infants, toddlers, children, ‘tweens, teens, and adults, along with exclusive décor and animatronics you won’t find anywhere else. For more information, please visit SpiritHalloween.com.

Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities law.

For further information, please contact:

Tilray Brands Media: news@tilray.com
Tilray Brands Investors: investors@tilray.com
Shock Top Media: tilraybeer@diffusionpr.com
Spirit Halloween: lori.tesoro@spirithalloween.com

Photos accompanying this announcement are available at: 

https://www.globenewswire.com/NewsRoom/AttachmentNg/1f8e6a2d-bbf7-4602-8293-b0e92a98aed4

https://www.globenewswire.com/NewsRoom/AttachmentNg/cadae521-4060-4ee1-a3c2-be46d39185a4

VANCOUVER, British Columbia, Sept. 16, 2026 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling premium and super-premium cannabis products, is pleased to announce its participation in investor and industry conferences across Canada this fall, including the SmallCap Discoveries Conference in Vancouver; Planet Microcap Toronto 2026; Science in the City International in Paris, France; and the 2026 CanExec Summit in Toronto.

“This fall’s conference schedule provides important opportunities to strengthen relationships with the investment community, engage with industry leaders, and elevate awareness of Rubicon Organics’ differentiated position in the global cannabis market,” said Margaret Brodie, Chief Executive Officer. “As we continue to execute our growth strategy, these forums allow us to showcase the strength of our premium brand portfolio, our expanding production capabilities, and our disciplined approach to pursuing select international opportunities.”

Ms. Brodie will present to investors at the SmallCap Discoveries Conference in Vancouver on September 29, 2026, and at Planet MicroCap Toronto on October 28, 2026. A webcast of the Planet MicroCap presentation will be available live and for replay via the link below. Rubicon Organics will also host one-on-one investor meetings at both events with Ms. Brodie and Glen Ibbott, Chief Financial Officer.

Rubicon Organics will also support Science in the City International as the educational sponsor. The cannabis industry symposium will be held September 28-29, 2026, in Paris, France, where Mathieu Aubin, Vice President, Marketing & New Business, will speak on the future of medical cannabis in France.

In October, Rubicon Organics will participate in the sixth annual CanExec Summit in Toronto, an exclusive networking and educational event for decision-makers from leading licensed producers. Melanie Ramsey, Chief Operating Officer, will participate in a panel on “The Cannabis Landscape: Building a Stronger Industry,” and Mr. Aubin will join the panel “Building a Global Cannabis Business” to discuss international opportunities.

Investor Presentation Details:

Event: 2026 SmallCap Discoveries Conference
Date: Tuesday, September 29, 2026
Time: 1:00 p.m. PT
Location: Parq Vancouver, Vancouver, British Columbia
Investors interested in meeting with Rubicon Organics at SmallCap Discoveries may register here.

Event: Planet MicroCap Toronto
Date: Wednesday, October 28, 2026
Time: 11:30 a.m. ET
Location: Arcadian Loft, Toronto, Ontario
Webcast: Link
Investors interested in meeting with Rubicon Organics at Planet MicroCap Toronto may register here.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics is the Canadian leader in certified organic and premium cannabis. With a vertically integrated model and strong national distribution, the company is scaling a house of trusted, high-performing brands including Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™.
  
The Company operates two complementary cultivation facilities in British Columbia: the flagship 125,000-square-foot Pacifica hybrid greenhouse in Delta and the 47,500-square-foot Cascadia indoor facility in Hope. Cascadia is now fully planted and operational, contributing to Rubicon’s total current annual production capacity of approximately 15,500 kilograms of premium cannabis.

With proprietary genetics, award-winning products, and certifications enabling international distribution, Rubicon is positioned at the forefront of the premium cannabis segment.
  
As the Canadian market continues to evolve and global demand for high-quality cannabis increases, Rubicon Organics’ disciplined execution, brand equity, and consumer loyalty set it apart. The Company’s continued focus on premium quality, thoughtful innovation, and operational excellence has supported steady revenue growth and positive Adjusted EBITDA.
  
Rubicon Organics represents a rare combination of category leadership, operational strength, and long-term growth potential.
  
For more information visit www.rubiconorganics.com.

CONTACT INFORMATION

Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com

The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding Rubicon Organics’ participation in upcoming investor and industry conferences, scheduled presentations, panels, webcasts and investor meetings, future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will”, “expected”, “anticipated”, “continue”, “positioned”, “opportunities”, “potential” or variations of such words or statements that certain actions, events or results may, could, would, should, might or will occur or be achieved.

Forward-looking statements are based on assumptions and estimates that management considers reasonable as of the date of this press release, including, among other things, assumptions regarding participation in upcoming investor and industry conferences, the timing and format of presentations, panels, webcasts and investor meetings, the continued strength of the Company’s premium brand portfolio, expansion of production capabilities, opportunities in select international markets, optimization of cultivation yields and operational efficiencies, successful ramp-up of production capacity, achievement of anticipated revenue growth, gross profit expansion, positive operating cash flow and Adjusted EBITDA profitability, and the Company’s ability to execute its strategic initiatives.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, among others, the risk that anticipated production, yield, operational efficiency, revenue, margin or profitability targets are not achieved, scheduled conferences, presentations, panels, webcasts or investor meetings are delayed, modified, cancelled or do not occur as planned, the risk that anticipated investor or industry engagement does not materialize, changes in market conditions, consumer demand, competition, regulatory developments, access to capital, and the other risk factors described under the heading “Risk Factors” in Rubicon Organics’ Annual Information Form dated March 23, 2026, filed with the Canadian securities regulatory authorities.

Readers are cautioned not to place undue reliance on forward-looking statements. Although the Company believes that the expectations and assumptions underlying such statements are reasonable, there can be no assurance that they will prove to be accurate, and actual results and future events may differ materially from those anticipated. Except as required by applicable law, Rubicon Organics undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

WATERTOWN, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) — EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employee as inducement award outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).

The Company granted stock options to purchase up to an aggregate of 3,000 shares of EyePoint common stock to one new employee. The stock options were granted on September 15, 2026. The grant was approved by the Compensation Committee and made as an inducement material to the employee entering into employment with EyePoint in accordance with NASDAQ Listing Rule 5635(c)(4). The option awards have an exercise price of $3.66 per share, the closing price of EyePoint’s common stock on September 15, 2026. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee’s date of grant and the remainder vesting in equal monthly installments over the following three years. Vesting of the options is subject to the employee’s continued service with EyePoint through the applicable vesting dates.

About EyePoint

EyePoint, Inc. (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases. The Company’s lead product candidate, DURAVYU™, is an innovative investigational sustained delivery treatment for serious retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor, in next-generation bioerodible Durasert E™ technology. Supported by robust safety and efficacy data across multiple clinical trials and indications, DURAVYU is currently being evaluated in Phase 3 pivotal trials for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Topline data for wet AMD was disclosed in August 2026 for LUGANO, and further data from LUCIA is expected in the fourth quarter of 2026. Topline data for DME is expected in the fourth quarter of 2027.

The Company is committed to partnering with the retinal community to improve patient lives while creating long-term value, with four approved drugs over three decades and tens of thousands of eyes treated with EyePoint innovation.

EyePoint is headquartered in Watertown, Massachusetts, with a commercial manufacturing facility in Northbridge, Massachusetts.

Vorolanib is licensed to EyePoint exclusively by Equinox Sciences, a Betta Pharmaceuticals affiliate, for the localized treatment of all ophthalmic diseases outside of China, Macao, Hong Kong and Taiwan.

DURAVYU™ has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for potential approval is uncertain.

Investors:
Robin Garner
EyePoint, Inc.
ir@eyepoint.bio

Media:
Helen O’Gorman
FTI Consulting
media@eyepoint.bio

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.